GFAP and brain injury: Myriad experimental and clinical investigations have demonstrated elevated levels of GFAP and UCH-L1 in cerebrospinal fluid (CSF) and blood samples from individuals following traumatic brain injury and stroke, with notable correlations established between these biomarkers and the severity and outcome of the respective conditions [26, 27].